3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Leukemia, Myeloid, Chronic-Phase
6
Neoplasm Metastasis
4
Neoplasms
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia
2
Synovitis, Pigmented Villonodular
1
Sarcoma
1
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Leukemia, Myeloid
1
Hematologic Diseases
1
Giant Cell Tumor of Tendon Sheath
1
Genital Neoplasms, Female
1
Gastrointestinal Stromal Tumors
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Chordoma
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Blast Crisis
1
Appendiceal Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
13
Prednisone
10
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
9
Doxorubicin
9
Vincristine
8
Azacitidine
6
romidepsin
5
Gemcitabine
5
Brentuximab Vedotin
5
fludarabine
4
Etoposide
4
Dexamethasone
4
pembrolizumab
3
belinostat
3
Lenalidomide
3
Biopsy
3
10-propargyl-10-deazaaminopterin
3
tazemetostat
2
ruxolitinib
2
ixazomib
2
duvelisib
2
Nivolumab
2
Bendamustine Hydrochloride
2
venetoclax
1
tislelizumab
1
thymoglobulin
1
spartalizumab
1
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
nilotinib
×
1 year
×
Clear all
No trials found.